Antiretroviral Drugs-Loaded Nanoparticles Fabricated by Dispersion Polymerization with Potential for HIV/AIDS Treatment.
Highly active antiretroviral (ARV) therapy (HAART) for chronic suppression of HIV replication has revolutionized the treatment of HIV/AIDS. HAART is no panacea; treatments must be maintained for life. Although great progress has been made in ARV therapy, HIV continues to replicate in anatomical and intracellular sites where ARV drugs have restricted access. Nanotechnology has been considered a platform to circumvent some of the challenges in HIV/AIDS treatment. Dispersion polymerization was used to fabricate two types (PMM and ECA) of polymeric nanoparticles, and each was successfully loaded with four ARV drugs (zidovudine, lamivudine, nevirapine, and raltegravir), followed by physicochemical characterization: scanning electron microscope, particle size, zeta potential, drug loading, and in vitro availability. These nanoparticles efficiently inhibited HIV-1 infection in CEM T cells and peripheral blood mononuclear cells; they hold promise for the treatment of HIV/AIDS. The ARV-loaded nanoparticles with polyethylene glycol on the corona may facilitate tethering ligands for targeting specific receptors expressed on the cells of HIV reservoirs.
Citations by journals
1
|
|
Polymers
|
Polymers
1 publication, 11.11%
|
Drug Delivery and Translational Research
|
Drug Delivery and Translational Research
1 publication, 11.11%
|
Beni-Suef University Journal of Basic and Applied Sciences
|
Beni-Suef University Journal of Basic and Applied Sciences
1 publication, 11.11%
|
European Journal of Pharmaceutics and Biopharmaceutics
|
European Journal of Pharmaceutics and Biopharmaceutics
1 publication, 11.11%
|
Colloids and Surfaces B: Biointerfaces
|
Colloids and Surfaces B: Biointerfaces
1 publication, 11.11%
|
Crystal Growth and Design
|
Crystal Growth and Design
1 publication, 11.11%
|
Journal of Drug Targeting
|
Journal of Drug Targeting
1 publication, 11.11%
|
Frontiers of Nanoscience
|
Frontiers of Nanoscience
1 publication, 11.11%
|
1
|
Citations by publishers
1
2
3
|
|
Elsevier
|
Elsevier
3 publications, 33.33%
|
Springer Nature
|
Springer Nature
2 publications, 22.22%
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
1 publication, 11.11%
|
American Chemical Society (ACS)
|
American Chemical Society (ACS)
1 publication, 11.11%
|
Taylor & Francis
|
Taylor & Francis
1 publication, 11.11%
|
1
2
3
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.